Dr Choo Su Pin

Dr Choo Su Pin

Biography

Dr Choo Su Pin

Senior Consultant & Chief
Division of Medical Oncology
Gastrointestinal Oncology Department

National Cancer Centre Singapore
Singapore


 

Dr Choo Su Pin is a Senior Consultant and Chief of the Gastrointestinal Cancer Service at the National Cancer Centre Singapore (NCCS). She is co-director of the Comprehensive Liver Cancer Clinic at NCCS and chair of the Singhealth Cancer Service Line for Liver Cancer. Dr Choo received her Medical Degree from the University of Nottingham in the United Kingdom. She has fellowships from the Royal College of Physicians, UK and the Academy of Medicine, Singapore. She trained in Gastrointestinal Oncology at NCCS and completed a one year fellowship at UCSF Comprehensive Cancer Center.

Dr Choo’s primary specialty is in medical oncology, with sub-specialties in colorectal, hepato-pancreato-biliary, upper gastrointestinal, and peritoneal-based malignancies. Areas of particular interest include hepatobiliary cancers and early phase trials, as well as emerging research in immuno-oncology approaches in hepato-biliary cancers.  She was a co-founding director of the Experimental Cancer Treatment Unit at NCCS and is now the Chair of the Clinical Trials Steering Committee at NCCS and Adjunct Principal Investigator at the Singhealth Investigational Medicine Unit. She has been competitive in research grants and has received government awarded research grants in hepatobiliary cancers.

She holds the positions of Adjunct Associate Professor, Singhealth Duke-NUS Oncology Academic Clinic Programme, Duke-NUS Graduate Medical School Singapore and Adjunct Associate Professor, Department of Medicine, Yong Loo Lin Medical School, National University of Singapore where she does both research mentorship and clinical teaching. Internationally, Dr Choo has served on advisory boards of pharmaceutical companies for gastrointestinal cancer drug development, delivered talks on hepatobiliary cancers at both national and international conferences and serves as an invited reviewer of the NCCN hepatobiliary cancer guidelines.